Medline Inc. 8K

Medline Inc. reported strong second-quarter and first-half 2026 sales growth but materially lower net income due to a major distribution center fire and cost pressures, recognized substantial IEEPA tariff refund benefits, and revised 2026 guidance to higher organic sales but lower Adjusted EBITDA.

On August 5, 2026, Medline Inc. reported its financial results for the second quarter and first six months of 2026, highlighting 11.6% year-over-year net sales growth to $7.7 billion and 11.1% growth to $15.0 billion for the half-year, alongside sharp declines in GAAP net income driven primarily by a $336 million loss related to a fire at its Tracy, California distribution center, higher operating expenses, and tariff impacts. The company recorded $243 million of net IEEPA tariff refund benefits (comprising $332 million of refunds offset by $89 million of accrued customer repayments), which boosted net income and Adjusted EBITDA and were fully recognized in the Medline Brand segment. Adjusted EBITDA increased 13.4% in the quarter to $1.06 billion and 1.9% for the first six months to $1.84 billion, with strong organic sales growth supported by existing customer expansion and new customer implementations. Medline also updated its full-year 2026 outlook, raising organic sales growth guidance to 9.0%–10.0% while lowering Adjusted EBITDA guidance to $3.3–$3.4 billion due to higher inflationary pressures linked to Middle East conflict, increased operational and quality remediation investments, and retail channel softness; the organic sales outlook includes IEEPA tariff customer repayments, while the Adjusted EBITDA outlook excludes any benefit from IEEPA tariff refunds.

Filing Facts

CIK

2046386

Ticker

MDLN

Form

8K

Source Type

sec

Accession

0002046386-26-000049

Alert Tier

7